Limited information is available regarding risk factors for the near-term (4 years) onset of myocardial infarction (MI). We evaluated established cardiovascular risk factors and putative circulating biomarkers as predictors for MI within 4 years of measurement.
RESULTS:
Among women and men, only 13% and 50%, respectively, of those with near-term MI were classified as high risk by Framingham risk score at baseline. After adjustment for established risk factors, odds ratios for near-term MI, which compared highest to lowest quintiles, were 2.87(95% CI 1.51-5.48; P ϭ 0.001) for ␣ lantitrypsin, 2.84(1.42-5.67; P ϭ 0.003) for C-reactive protein, 1.97(1.09 -3.57; P ϭ 0.03) for creatinine, 1.99(1.09 -3.65; P ϭ 0.03) for fibrinogen, and 0.37(0.19 -0.73; P ϭ 0.004) for iron. The corresponding odds ratio for all biomarkers combined was 7.24 (3.28 -16.0; P Ͻ 0.001).
CONCLUSIONS:
We identified 5 biomarkers associated with increased near-term risk of MI independently of established risk factors. All putative biomarkers combined explained a 7-fold increase in the odds of nearterm MI.
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Atherosclerotic cardiovascular disease (CVD) 7 is predominantly caused by modifiable risk factors but nonetheless remains the leading cause of death and severe disability worldwide (1 ) . For CVD prevention, American and European guidelines recommend an integrated 2-step approach in which risk assessment (prediction) is followed by individualized risk reduction (therapy) as needed; the higher the risk, the more aggressive the prescribed preventive care (2) (3) .
Risk assessment in primary prevention of atherosclerotic CVD has not changed dramatically in the last 40 years. It continues to be based on the risk factor concept introduced by the Framingham Heart Study in the 1960s (4 ) . Because individual risk factors such as total cholesterol and blood pressure have low independent predictive abilities (5 ) they have been combined to generate global risk assessment measures such as the Framingham risk score and the European Systematic Coronary Risk Evaluation (2) (3) . These multivariable risk prediction models provide estimates of 10-year absolute risk and relative risk. The absolute risk is used primarily to assess the need for pharmacological risk reduction, whereas the relative risk is more useful in identifying younger individuals who would benefit from lifestyle modification to reduce their otherwise high lifetime risk for atherosclerotic CVD.
Although this 2-step preventive approach is sound, it is far from perfect because currently established risk factors have limited predictive power even when combined (6 ) , and progression of subclinical atherosclerosis to clinical events still occurs despite initiation of the recommended "optimal" therapy (7 ).
Most events occur in Framingham risk score/European Systematic Coronary Risk Evaluation low-and intermediate-risk categories (i.e., among misclassified individuals), and a substantial residual risk persists even with the best available medical therapy (7) (8) (9) . Thus, there is a need to improve both the detection and the treatment of those individuals at highest risk for atherosclerotic CVD.
The purpose of the present study was to improve the detection of individuals at highest risk by focusing on those who develop myocardial infarction (MI) within 4 years after risk assessment. Risk factors and predictors of such near-term MI have not been reported before, largely because most studies are too small to accumulate sufficient numbers of near-term MI events. Clearly, risk factors for near-term events like MI largely determined by thrombosis superimposed on inflamed and ruptured atherosclerotic plaques could differ from risk factors for longer-term events largely associated with slow development of atherosclerosis. For this purpose, we used a large, communitybased, prospective, nested case-control study, the Copenhagen City Heart Study combined with the Copenhagen General Population Study, which includes 45 735 men and women.
Materials and Methods

STUDY POPULATION
Participants were from the 2001-2003 examination of the Copenhagen City Heart Study and from the 2003-2007 examination of the Copenhagen General Population Study. The Copenhagen City Heart Study is a prospective cardiovascular population study of the Danish general population initiated in 1976 comprising white men and women of Danish descent attending 1 or several examinations (10 ) . During the 2001-2003 examination, blood samples were collected from 5907 individuals (50% participation rate). The Copenhagen General Population Study is a prospective study of the Danish general population initiated in 2003 and still recruiting participants (10, 11 ) . The goal is to recruit a total of 100 000 participants selected exactly as the participants of the Copenhagen City Heart Study. Between 2003 and 2007, 39 828 individuals from the Copenhagen General Population Study returned blood samples (45% participation rate). Within 4 years of blood draw in the combined studies, 252 participants with incident nonfatal or fatal MI were identified. Controls were matched to cases from the same study, randomly selected in a 2:1 ratio from participants with a blood sample and without a history of MI, and matched for age (within 1 year), sex, year of examination and of blood draw (within 1 year), and HMG-CoA (3-hydroxy-3-methyl-glutaryl coenzyme A) reductase inhibitor use (yes or no). A history of previous angina pectoris including revascularization procedures was allowed among both cases (11%) and controls (6%).
We collected and verified information on diagnoses of MI (WHO; International Classification of Diseases, 8th edition: codes 410; 10th edition: codes I21-I22) by reviewing all hospital admissions and diagnoses entered in the national Danish Patient Registry; medical records from hospitals and general practitioners were used to verify MI diagnoses that generally required the presence of at least 2 of the following criteria: characteristic chest pain, increased cardiac enzymes, and electrocardiographic changes indicative of MI. Five cases were matched to only 1 control instead of 2. A total of 252 cases and 499 controls were thus available for analysis.
These studies were approved by Herlev Hospital and by Danish ethics committees. Participants gave written informed consent.
ESTABLISHED RISK FACTORS
We measured nonfasting total cholesterol, HDL cholesterol, and triglycerides (Boehringer Mannheim) on fresh plasma. LDL cholesterol was calculated by the Friedewald formula if triglycerides were Ͻ4 mmol/L, but measured directly at higher triglyceride concentrations. Smoking status was defined as never, past, or current smokers. The label of diabetes mellitus was assigned if there was self-reported disease, use of insulin or oral hypoglycemic agents, and/or nonfasting plasma glucose Ͼ11 mmol/L. Physical inactivity was designated whenever leisure-time activity was less than 4 h weekly with predominantly sedentary work. Body mass index was weight (kg) divided by height squared (m 2 ). Blood pressure was measured after 5 min of rest, and with the individual in the sitting position. Family history of premature MI was defined as MI in a male firstdegree relative before age 55 years or MI in female firstdegree relative before age 65 years.
PUTATIVE CIRCULATING BIOMARKERS
From nonfasting fresh blood samples, 14 biochemical variables were measured by using colorimetric and turbidimetric assays (Konelab, Dade Behring, ILS Laboratories, Allerød, or Dako) or flow cytometry (Bayer). These biochemical variables included high-sensitivity C-reactive protein (hs-CRP), fibrinogen, ␣ 1 -antitrypsin, complement component 3 (complement C3), apolipoprotein A1, apolipoprotein B, apolipoprotein E, iron, transferrin, creatinine, alkaline phosphatase, ␥-glutamyl transpeptidase, lymphocyte count, and neutrophil count. Transferrin saturation (%) was calculated by dividing serum iron concentration (mol/L) by 2ϫ the transferrin concentration (mol/L).
STATISTICAL ANALYSIS
Variables were compared at baseline between cases and controls, taking into account matching. Because the matching was in a 2:1 ratio and not in a 1:1 ratio, random intercept mixed models for continuous variables and conditional logistic regression for categorical variables were used for the baseline comparison between cases and controls. Baseline is defined as the date of blood draw for each study participant. Correlations between variables were calculated by using Spearman correlation.
Conditional logistic regression was used to examine associations between individual baseline variable levels and incidence of MI. Levels of continuous variables were categorized into quintiles based on their distribution among controls. We evaluated 17 baseline biomarker variables: ␣ l -antitrypsin, alkaline phosphatase, apolipoprotein A1, apolipoprotein B, apolipoprotein E, complement C3, creatinine, fibrinogen, ␥-glutamyl transpeptidase, iron, transferrin, transferrin saturation, hs-CRP, lymphocyte count, neutrophil count, the ratio of neutrophil count to lymphocyte count, and the ratio of apolipoprotein B to apolipoprotein A1. We constructed 2 statistical models. One model considered the variable under evaluation with no adjustment for other risk factors. A second model was multivariable and adjusted for 9 established baseline risk factors: total cholesterol (in quintiles based on controls), HDL cholesterol (in quintiles based on controls), triglycerides (in quintiles based on controls), 5 blood pressure categories (systolic/diastolic pressure Ͻ120/80 mmHg, Ն120/80 and Ͻ130/85 mmHg, Ն130/85 and Ͻ140/90 mmHg, Ն140/90 and Ͻ160/ 100 mmHg, and Ն160/100 mmHg or use of antihypertensive therapy), smoking status (never smoked, current smoker, former smoker), diabetes mellitus (yes/ no), family history of premature MI (yes/no), body mass index (treated as a continuous variable), and physical activity (dichotomized, Ͻ4 h of activity per week and sedentary work, or Ͼ4 h of activity per week and/or nonsedentary work). A distinct conditional logistic regression model that did not consider any biomarkers and comprised solely the 9 established baseline risk factors categorized as described above was also evaluated. The likelihood-ratio test was used to determine whether a logistic regression model that included the variable of interest provided a better fit than did a logistic regression model without the variable. We assessed model goodness of fit by using the Hosmer and Lemeshow test, and did not find any significant lack of fit. To test for linear trend across categories, median levels within quintiles were used as a continuous measure.
In a separate, secondary analysis, ROC curves were calculated, with the binary outcome of occurrence of MI, for models comprising different numbers of biomarkers. Areas under ROC curves (AUCs) were compared, for which we took into account correlation between areas (12, 13 ) . For these calculations of AUCs we investigated both conditional logistic regression models and unconditional logistic regression models, adjusting for the matching factors. Because both analyses yielded essentially the same results, we present here the results using unconditional logistic regression adjusted for the matching factors. Of the 17 baseline biomarker variables, 4 biomarker variables were not included in this secondary analysis owing to high correlation with other biomarkers. Specifically, serum iron and transferrin were removed (in favor of transferrin saturation), the ratio of neutrophil count to lymphocyte count was removed (neutrophil count and lymphocyte count individually were retained), and the ratio of apolipoprotein B to apolipoprotein A1 was removed (apolipoprotein B and apolipoprotein A1 individually were retained). As such, 13 biomarker variables were considered. Established risk factors were categorized as previously, and biomarker concentrations for this secondary analysis were considered as continuous variables and logarithmic transformation was performed to normalize their distributions. Separately, the association of the composite set of these 13 biomarker variables with outcome was evaluated as follows. First, ␤ coefficients associated with each of the 13 biomarker variables were estimated by using a conditional logistic regression model that included the 13 biomarkers and the 9 established risk factors. The linear combination of the 13 biomarker variables, each multiplied by a constant equal to the respective estimated ␤ coefficient, defined a multimarker score. Subsequently, this multimarker score was categorized into quintiles, and the odds ratio associated with each quintile of the score, with the lowest quintile serving as the referent, was calculated using conditional logistic regression for the binary outcome of occurrence of MI.
Study participants with missing measurements in any of the 17 blood-based biomarker variables of interest or any of the 9 established baseline risk factors were excluded. The final dataset for statistical analysis thus consisted of 699 individuals, comprising 236 cases and 463 matched controls.
All P values were 2 tailed. Adjustment for multiple comparisons was performed by controlling the false discovery rate (14 ) ; by controlling type I errors the false discovery rate adjustment addresses false positives attributable to multiple testing. Probability values Ͻ0.05 with the false discovery rate controlled at 0.2 were considered significant. All CIs were calculated at the 95% level. Statistical analyses were conducted with the use of SAS software, version 9 (SAS Institute), and R software, version 2.
Results
Using the sex-specific risk equations published by the Framingham Heart Study (15 ), we calculated the 10-year absolute risk for the entire study population at baseline. Only 38% of all near-term MI events occurred in those categorized as high risk (Table 1) . By sex, only 13% of all near-term MI in females occurred in those in the high-risk category, whereas 50% of near-term MI in males occurred in the high-risk category.
RISK FACTORS
Baseline characteristics for the study population, including some of the major cardiovascular risk factors identified in longer-term studies are shown in Table 1 . In a model comprising 9 of these established risk factors, HDL cholesterol, smoking status (currently smoking), and presence of diabetes were significantly associated with near-term incident MI (Table 2 ). Cases and controls were matched for age and sex in the present study, and as such age and sex were not included in the model.
After adjustment for established risk factors, 5 of 17 putative biomarkers remained individually associated with 4-year risk of MI (based on statistical significance of comparison of highest and lowest quintiles, likelihoodratio test, and monotonicity of trend across quintiles): odds ratios comparing highest to lowest quintiles were 2.87 (95% CI 1.51-5.48; P ϭ 0.001) for ␣ l -antitrypsin, 2.84 (1.42-5.67; P ϭ 0.003) for C-reactive protein, 1.97 (1.09 -3.57; P ϭ 0.03) for creatinine, 1.99 (1.09 -3.65; P ϭ 0.03) for fibrinogen, and 0.37 (0.19 -0.73; P ϭ 0.004) for iron (Table 3, and Table S1 in the Data Supplement that accompanies the online version of this article at http:// www.clinchem.org/content/vol56/issue4). Results for 2 other biomarkers, apolipoprotein A1 and transferrin saturation, were statistically significant based on comparison of highest and lowest quintiles. The odds ratios associated with quintiles of a composite multimarker score comprising 13 biomarkers were significant in both unadjusted and adjusted models, with univariate and multivariate adjusted odds ratios for highest quintile relative to lowest quintile of 9.83 (95% CI 4.95-19.5; P Ͻ 0.001) and 7.24 (3.28 -16.0; P Ͻ 0.001) ( Table 4 ). This multimarker score consists of a linear combination of the following 13 biomarkers, as indicated in the Table 4 legend: ␣ 1 -antitrypsin, alkaline phosphatase, apolipoprotein A1, apolipoprotein B, apolipoprotein E, complement C3, creatinine, fibrinogen, ␥-glutamyl transpeptidase, transferrin saturation, hs-CRP, lymphocyte count, and neutrophil count.
The concentrations of hs-CRP, fibrinogen, and ␣ 1 -antitrypsin showed a moderate degree of correlation with each other, as did C-reactive protein and body mass index (see online supplemental Table S2 ). The concentrations of a number of other established risk factors and putative biomarkers were also associated. 
PREDICTIVE VALUE
With the addition of multiple biomarkers to the 9 established risk factors (see online supplemental Fig. S1 ), the AUC increased from 0.706 to 0.745 (Table 5) ; this increase achieved statistical significance on addition of all 13 biomarkers to the 9 established risk factors (P for difference in AUC ϭ 0.001). Improvements for individual cases and controls are illustrated in online supplemental Fig. S2 .
There was considerable overlap in the frequency distributions of individual established risk factors and biomarkers in study participants who developed an MI and those who did not. Fig. 1A shows the frequency distribution of C-reactive protein as an example. The composite multimarker score exhibited relatively less overlap in frequency distribution between events and nonevents (Fig. 1B) .
Discussion
The results of present study in apparently healthy men and women show that some established risk factors for 10-year and life-time risks of MI are also associated with near-term (4-year) risk of MI. In addition, we found that 5 among 17 putative biomarkers were independently associated with near-term MI and improved risk model fit after adjustment for established risk factors. Most events occurred in people belonging to the low or intermediate Framingham risk categories, particularly among females.
The most common cause of MI is rupture of an inflamed fibrous cap of a vulnerable plaque leading to coronary thrombosis (16 ) . It has been suggested that systemic markers of inflammation and/or a prothrombotic state would be particularly predictive for such local inflammation-related atherothrombotic events (17 ) . To assess this hypothesis, we included several inflammation-sensitive plasma proteins in our putative biomarker panel (hs-CRP, fibrinogen, ␣ 1 -antitrypsin, and complement component 3), of which some also might promote thrombosis. Three of these inflammation-related biomarkers were independently associated with increased risk of a near-term MI, but the question is how to interpret these findings.
The association between hs-CRP and near-term MI was virtually identical to that previously reported in both short-term (18 ) and longer-term studies (19 ) , consistent with observations that indicate that hs-CRP is neither a marker nor a mediator of atherothrombosis (20 ) . Previously, we found no association between hs-CRP concentrations in the blood and local inflammation (macrophage density) in symptomatic carotid plaques removed by surgery (21 ) , which argues against a direct link between circulating C-reactive protein and inflammation in a single high-risk (vulnerable) or symptomatic plaque. Furthermore, results of a large genetic epidemiological study based on the principle of Mendelian randomization provided no support for a causal role of C-reactive protein in atherothrombosis and MI (22 ) . Despite large sample sizes, negative Mendelian randomization studies still have limitations, and must be evaluated in the context of other evidence favoring or disfavoring causality between C-reactive protein and MI (23 ) . Nevertheless, hs-CRP could still be useful clinically in risk assessment and management of individuals at risk for MI (23) (24) (25) . Baseline frequency distributions of (A) C-reactive protein and (B) multimarker score comprising 13 biomarkers. Left panels show histograms, and right panels show fitted distribution functions (using kernel density estimation method). Horizontal axes are on a natural logarithm scale. White bars and solid curves correspond to MI case patients. Black bars and dashed curves correspond to control individuals. The 13 biomarkers of the multimarker score are ␣ 1 -antitrypsin, alkaline phosphatase, apolipoprotein A1, apolipoprotein B, apolipoprotein E, complement C3, creatinine, fibrinogen, ␥-glutamyl transpeptidase, transferrin saturation, C-reactive protein, lymphocyte count, and neutrophil count; arb., arbitrary.
Among the other systemic inflammation-sensitive proteins assessed in the present study, fibrinogen deserves special attention because of its multifunctional role in inflammation, plasma viscosity, coagulation, and platelet aggregation (26 ) . The strength of association between fibrinogen and near-term MI was similar to that previously reported in longer-term studies. However, a possible causal role of fibrinogen in atherothrombosis and MI has not been substantiated in genetic epidemiological studies (Mendelian randomization) and remains hypothetical (27 ) .
As previously observed in longer-term studies (28 ), ␣ 1 -antitrypsin was also associated with near-term risk of MI with a strength comparable to that of hs-CRP and fibrinogen. Indeed, these 3 inflammation-sensitive plasma proteins correlated positively with each other in the present study. ␣ 1 -Antitrypsin, synthesized primarily in the liver as well as by neutrophils and monocyte/ macrophages, is the main proteinase inhibitor in human plasma. Its concentration has been reported to be relatively high in human atherosclerotic lesions (29 ) . Genetic ␣ 1 -antitrypsin deficiency is associated with reduced risk of MI but also with reduced blood pressure (30 ) . The latter is a confounding factor regarding a possible causal role of ␣ 1 -antitrypsin in atherothrombosis and MI.
Markers of iron overload (high serum iron and transferrin saturation) were associated with reduced risk of a near-term MI. Results from longer-term epidemiological studies are conflicting but, overall, do not support the existence of a strong association between iron status and MI (31 ) . Iron overload caused by mutations in the hemochromatosis gene does not seem to influence the risk of MI substantially (32 ) . Nevertheless, the observed associations between low serum iron and transferrin saturation and increased risk of a nearterm MI in an apparently healthy population deserve to be explored further.
Chronic renal failure is associated with a markedly increased risk of CVD (33 ) , but conflicting results have been reported on the association between creatinine and long-term risk of MI in the general population. In our study, those in the top quintile had a double risk of a near-term MI compared with the bottom quintile after adjustment for established risk factors, including blood pressure and use of antihypertensive medication. Furthermore, creatinine did not correlate with any of the inflammation-sensitive proteins (hs-CRP, fibrinogens, ␣ 1 -antitrypsin). Possible explanations for the increased risk of CVD seen with increased serum creatinine concentrations have been discussed previously (33 ) .
In the present study, only 13% of all near-term MI in females occurred in those categorized as high risk at baseline by the Framingham risk score. In men, about 50% of near-term MI occurred in the high-risk category. Although such depressing results are rarely reported directly, they can be computed from published data and seem to reflect the reality. In the Framingham Heart Study (34 ), the Physicians' Health Study (35 ) , the Women' Health Study (36 ) , and the Northwick Park Heart Study (37 ) more than 75% of all hard coronary events occurred in people classified at low or intermediate risk. Risk assessment is particularly difficult and unreliable in women.
LIMITATIONS
The study population comprised individuals who are racially and ethnically homogeneous, namely white men and women of Danish descent. Although such homogeneity likely somewhat increased statistical power to observe certain associations, additional follow-up studies in more heterogeneous populations would be necessary for generalization of the results presented here. In addition, because the current analysis is exploratory, it requires validation in other populations. In addition, our matched, nested case-control design was designed to investigate biomarker association with outcome, and as such, it is not conducive to calculating absolute risks.
Conclusions
We identified 5 biomarkers associated with increased near-term (4 years) risk of MI independently of established risk factors. All putative biomarkers combined explained a 7-fold increased odds of near-term MI.
